Arvinas

$76.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.87 (+2.52%) Today

$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Arvinas and other stocks, options, and ETFs commission-free!

About ARVN

Arvinas, Inc. Common Stock, also called Arvinas, is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT. The listed name for ARVN is Arvinas, Inc. Common Stock.

CEO

John G. Houston

Employees

133

Headquarters

New Haven, Connecticut

Founded

2013

Market Cap

3.95B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

458.50K

High Today

$77.99

Low Today

$74.40

Open Price

$74.91

Volume

289.65K

52 Week High

$92.77

52 Week Low

$19.68

Analyst Ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

ARVN Earnings

-$0.79

-$0.46

-$0.12

$0.21

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, Pre-Market